​

Acumen Pharmaceuticals Ownership | Who Owns Acumen Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Acumen Pharmaceuticals Ownership Summary

Acumen Pharmaceuticals is owned by 62.09% institutional investors, 11.46% insiders, and 26.45% retail investors. Ra capital management is the largest institutional shareholder, holding 24.65% of ABOS shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.44% of its assets in Acumen Pharmaceuticals shares.

ABOS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAcumen Pharmaceuticals62.09%11.46%26.45%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management14.93M24.65%$17.32M
Sands capital ventures3.42M5.64%$3.96M
Franklin resources3.27M5.45%$5.63M
Blackrock2.16M3.61%$5.22M
Fmr2.02M3.37%$3.48M
Vanguard group1.94M3.23%$3.34M
Knollwood investment advisory1.63M2.69%$1.89M
Millennium management1.14M1.88%$1.25M
Jpmorgan chase937.91K1.56%$1.61M
Alyeska investment group939.60K1.55%$1.09M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sands capital ventures3.42M0.78%$3.96M
Ra capital management14.93M0.29%$17.32M
Knollwood investment advisory1.63M0.18%$1.89M
Adar1 capital management916.18K0.16%$1.06M
Ikarian capital265.77K0.06%$308.29K
Laurion capital management lp867.05K0.02%$1.01M
Intrepid financial planning group30.15K0.01%$34.97K
Catalyst financial partners89.70K0.01%$104.05K
Y-intercept (hong kong)250.85K0.01%$290.98K
Bridgeway capital management134.00K0.01%$230.48K

Top Buyers

HolderShares% AssetsChange
Blackrock2.16M0.00%1.97M
Jpmorgan chase937.91K0.00%874.84K
Adar1 capital management916.18K0.16%770.00K
Y-intercept (hong kong)250.85K0.01%250.85K
Marshall wace, llp137.94K0.00%137.94K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de291.96K--2.04M
Rock springs capital management lp---1.84M
Parkman healthcare partners---576.66K
Franklin resources3.27M0.00%-275.44K
Tang capital management---246.90K

New Positions

HolderShares% AssetsChangeValue
Y-intercept (hong kong)250.85K0.01%250.85K$290.98K
Marshall wace, llp137.94K0.00%137.94K$160.01K
Hrt financial lp31.43K0.00%31.43K$36.00K
Point72 asia (singapore) pte.21.34K0.00%21.34K$24.75K
Ethic11.38K0.00%11.38K$12.74K

Sold Out

HolderChange
Capital performance advisors llp-52.00
Russell investments group-278.00
Coldstream capital management-311.00
Nisa investment advisors-356.00
Rise advisors-373.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202572-13.25%37,610,957-6.52%621.41%3119.23%24-29.41%
Mar 31, 20255-93.83%16,490,041-61.19%270.54%1-97.50%2-90.00%
Dec 31, 2024815.19%42,494,401-2.55%701.34%4017.65%20-4.76%
Sep 30, 202477-10.47%43,605,2660.06%721.37%34-24.44%2110.53%
Jun 30, 2024862.38%43,581,2970.50%721.30%45-8.16%19-13.64%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Franklin Biotechnology Discv A(acc)USD1.48M2.44%-
Fidelity Select Health Care1.14M1.88%-
Vanguard Total Stock Mkt Idx Inv1.12M1.85%-24.52K
iShares Russell 2000 ETF971.80K1.60%-
Franklin Biotechnology Discovery A826.40K1.36%-
Franklin US Small Cap Growth Equity771.94K1.27%3.97K
Franklin Small Cap Growth SMA771.94K1.27%771.94K
Franklin Small Cap Growth Adv708.38K1.17%-59.59K
Fidelity Advisor Health Care I700.00K1.16%-
Fidelity Small Cap Index408.40K0.67%-

Recent Insider Transactions

DateNameRoleActivityValue
Jan 21, 2025Zuga Matt CFO & Chief Business OfficerSell$6.99K
Jan 23, 2025Zuga Matt CFO & Chief Business OfficerSell$49.63K
Jan 21, 2025OConnell Daniel Joseph Chief Executive OfficerSell$20.10K
Jan 21, 2025Meisner Derek M Chief Legal Officer & Corp SecSell$5.43K
Jan 21, 2025Barton Russell Chief Operating OfficerSell$4.69K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1-11
2024 Q4--
2024 Q2--
2024 Q1-5

ABOS Ownership FAQ

Who Owns Acumen Pharmaceuticals?

Acumen Pharmaceuticals shareholders are primarily institutional investors at 62.09%, followed by 11.46% insiders and 26.45% retail investors. The average institutional ownership in Acumen Pharmaceuticals's industry, Biotech Stocks , is 304.14%, which Acumen Pharmaceuticals falls below.

Who owns the most shares of Acumen Pharmaceuticals?

Acumen Pharmaceuticals’s largest shareholders are Ra capital management (14.93M shares, 24.65%), Sands capital ventures (3.42M shares, 5.64%), and Franklin resources (3.27M shares, 5.45%). Together, they hold 35.74% of Acumen Pharmaceuticals’s total shares outstanding.

Does Blackrock own Acumen Pharmaceuticals?

Yes, BlackRock owns 3.61% of Acumen Pharmaceuticals, totaling 2.16M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 5.22M$. In the last quarter, BlackRock increased its holdings by 1.97M shares, a 1037.95% change.

Who is Acumen Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sands capital ventures is Acumen Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.78% of its assets in 3.42M Acumen Pharmaceuticals shares, valued at 3.96M$.

Who is the top mutual fund holder of Acumen Pharmaceuticals shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of Acumen Pharmaceuticals shares, with 2.44% of its total shares outstanding invested in 1.48M Acumen Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools